GANX vs MOS · $53.0M cap vs P/E 161, rev $5.82B
Gain Therapeutics Inc (GANX) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
GANX does not have a complete income-statement cache yet.
Latest reported MOS revenue for 2026-06-30 was $5.82B. Net income was -$530.4M. Revenue was up 94.2% from 2026-03-31 to 2026-06-30. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
GANX currently screens at market cap $53.0M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the GANX and MOS stock pages for the full models.
Not investment advice.